【摘要】 目的:进行阿奇霉素、头孢唑肟钠、左氧氟沙星、头孢曲松钠治疗下呼吸道感染的药学分析。方法:选择2013年4月—2015年9月期间在我院接受治疗的下呼吸道感染患者180例作为研究对象,随机分为A、B、C、D四组,分别接受阿奇霉素、头孢唑肟钠、左氧氟沙星、头孢曲松钠治疗,比较四组患者的治疗效果。结果:四组患者在治疗有效率方面差异无统计学意义,P>0.05,但是不同抗生素种类的价格差距较大。结论:阿奇霉素、头孢唑肟钠、左氧氟沙星、头孢曲松钠治疗下呼吸道感染效果差异无统计学意义,但是左氟沙星和阿奇霉素的药品价格更低。更多还原

【Abstract】 Objective: Pharmaceutical analysis of Azithromycin, cefazolin sodium oxime, levofloxacin, and ceftriaxone sodium in the treatment of lower respiratory infection. Methods: 180 patients with lower respiratory tract infection from April 2013 to September 2015 were randomly divided into A,B,C,D four groups, accepted azithromycin, cefazolin sodium oxime,levofloxacin, and ceftriaxone sodium treatment, respectively. The therapeutic effect of four groups was compared. Results: For patients there was no statistically significant difference between those four groups in treatment efficiency(P>0.05),but there was a big price gap between different types of antibiotics. Conclusion: Azithromycin, cefazolin sodium oxime, levofloxacin, and ceftriaxone sodium showed no statistically difference in the effect of treatment of lower respiratory tract infection, but left fluorine and azithromycin are much lower in drug prices.更多还原